Fondazione Telethon:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Fondazione Telethon - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9417
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Fondazione Telethon (Telethon) is a non-profit healthcare organization that funds and invests for projects in the area of biomedical research on genetic diseases. The organization develops projects by offering support services for increasing the horizons of therapeutic application to new researchers. Its business activities include raising funds and allocation of funds to evaluated and approved research projects; managing internal research institutes; and managing research funding allocated to external entities such as universities, rehabilitation centers, and hospitals with basic research in the laboratory. Telethon cures rare genetic diseases by raising funds for conducting biomedical research. The organization has operations in Rome and Milan, Italy. Telethon is headquartered in Rome, Italy.

Fondazione Telethon – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Fondazione Telethon, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Fondazione Telethon, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Fondazione Telethon, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Fondazione Telethon, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Fondazione Telethon, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Fondazione Telethon, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Casma Therapeutics Enters into Research Agreement with Fondazione Telethon 10
Editas Medicine Enters into Agreement with Fondazione Telethon and Ospedale San Raffaele 11
Biogen Idec, Fondazione Telethon and Ospedale San Raffaele Enter into Agreement to Develop Gene Therapies for Hemophilia 12
Shire Enters Into Research Agreement With Fondazione Telethon 13
Fondazione Telethon – Key Competitors 14
Fondazione Telethon – Key Employees 15
Fondazione Telethon – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Fondazione Telethon, Pharmaceuticals & Healthcare, Key Facts 2
Fondazione Telethon, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Fondazione Telethon, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Fondazione Telethon, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Fondazione Telethon, Deals By Therapy Area, 2012 to YTD 2018 8
Fondazione Telethon, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Casma Therapeutics Enters into Research Agreement with Fondazione Telethon 10
Editas Medicine Enters into Agreement with Fondazione Telethon and Ospedale San Raffaele 11
Biogen Idec, Fondazione Telethon and Ospedale San Raffaele Enter into Agreement to Develop Gene Therapies for Hemophilia 12
Shire Enters Into Research Agreement With Fondazione Telethon 13
Fondazione Telethon, Key Competitors 14
Fondazione Telethon, Key Employees 15
Fondazione Telethon, Other Locations 16

List of Figures
Fondazione Telethon, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Fondazione Telethon, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Fondazione Telethon, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Fondazione Telethon, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Fondazione Telethon, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Fondazione Telethon, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Fondazione Telethon, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Fondazione Telethon, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Fondazione Telethon:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Expanesthetics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Expanesthetics Inc (Expanesthetics) is a developer of anesthetic and analgesic agents. The company develops inhalation anesthetic agents used in surgical procedures. It offers CNS drug development programs for various types of pains and indications such as post-operative pain, traumatic inju …
  • John Keells Holdings PLC (JKH.N0000):企業の財務・戦略的SWOT分析
    Summary John Keells Holdings PLC (John Keells) is a business and consumer services company that provides hotel management services. The company offers services such as airline and aviation services, cinnamon hotels and resorts services, holiday and tour consulting services, port and marine fuel serv …
  • Ortivus AB (ORTI B):企業の財務・戦略的SWOT分析
    Summary Ortivus AB (Ortivus) is a supplier of mobile solutions for emergency medical care. The company develops and offers cardiology, and mobile monitoring and communication solutions. Its products include MobiMed Smart, CoroNet, excense heart record system and excense decision support healthcare s …
  • Jacobs Engineering Group Inc (JEC)-エネルギー分野:企業M&A・提携分析
    Summary Jacobs Engineering Group Inc. (Jacobs) is a provider of technical professional services. The company offers a diverse range of technical, professional, and construction services to industrial, commercial, and governmental customers across the globe. Its service portfolio includes project; pr …
  • Odakyu Electric Railway Co Ltd (9007):企業の財務・戦略的SWOT分析
    Odakyu Electric Railway Co Ltd (9007) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • LifeScan Inc:医療機器:M&Aディール及び事業提携情報
    Summary LifeScan Inc (LifeScan), a subsidiary of the Johnson & Johnson, develops, manufactures and markets blood glucose monitoring solutions for hospital and home use. The company’s product portfolio includes blood glucose meters; test strips and control solutions; lancing devices; diabetes managem …
  • ENN Energy Holdings Ltd (2688):石油・ガス:M&Aディール及び事業提携情報
    Summary ENN Energy Holdings Ltd (ENN) is a clean energy distributor that offers sales and distribution of piped gas, LNG and other energy products. The company conducts investment, operation and management of gas pipeline infrastructure, wholesale of gas, the sales, distribution of piped gas and oth …
  • DHL Parcel UK Ltd:企業の戦略的SWOT分析
    DHL Parcel UK Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Australian Pharmaceutical Industries Ltd (API):企業の財務・戦略的SWOT分析
    Australian Pharmaceutical Industries Ltd (API) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Explaurum Ltd (EXU):企業の財務・戦略的SWOT分析
    Summary Explaurum Ltd (Explaurum) is a mining and mineral exploration company. The company carries out the business of acquisition, exploration, and development of precious and base metals deposits. It explores for copper, gold, silver, zinc, molybdenum, lead, tin, phosphates, aluminium, uranium and …
  • Romaero SA Bucuresti:企業の戦略・SWOT・財務分析
    Romaero SA Bucuresti - Strategy, SWOT and Corporate Finance Report Summary Romaero SA Bucuresti - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Henkel AG & Co. KGaA:企業のM&A・事業提携・投資動向
    Henkel AG & Co. KGaA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Henkel AG & Co. KGaA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Olink Proteomics AB-医療機器分野:企業M&A・提携分析
    Summary Olink Proteomics AB (Olink) is a biotechnology company that provides products and services for human protein biomarker research. The company’s portfolio of products includes biomarkers, cardiovascular diseases panels, neurological disease panels, inflammation panels and oncology panels. Olin …
  • Leadiant Biosciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Leadiant Biosciences Inc (Leadiant Biosciences) a subsidiary of Sigma-Tau SpA is a pharmaceutical company that discovers and develops novel medicines. The company offers products such as Cystaran, Carnitor, Matulane, Adagen, Abelcet, DepoCyt, ProXeed Plus, VSL and Colief products. It offers …
  • Mondelez International Inc (MDLZ):企業の財務・戦略的SWOT分析
    Mondelez International Inc (MDLZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Italiaonline SpA:企業の戦略的SWOT分析
    Italiaonline SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Royal DSM NV (DSM):企業の財務・戦略的SWOT分析
    Royal DSM NV (DSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • OncoTherapy Science Inc (4564):製薬・医療:M&Aディール及び事業提携情報
    Summary OncoTherapy Science Inc (OncoTherapy) is a biotechnology company that discovers and develops antibody drugs for treating cancer. The company offers products under antibodies, cancer vaccines and small molecule drugs. It provides contract research services. OncoTherapy conducts research and d …
  • Avacta Group Plc (AVCT):製品パイプライン分析
    Summary Avacta Group Plc (Avacta) is a developer therapeutic molecules used in a wide range of life sciences applications in research and diagnostics. The company offers products which include optim and sensipod. It also develops UCB celltech, which is an analytical instrument. Avacta’s sensipod is …
  • IMCD N.V.:企業のM&A・事業提携・投資動向
    IMCD N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's IMCD N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆